Skip to main content
Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
3.560
-0.120 (-3.26%)
Apr 28, 2026, 4:00 PM EDT - Market closed

MRVI Revenue

In the year 2025, Maravai LifeSciences Holdings had annual revenue of $185.74M, down -28.34%. Maravai LifeSciences Holdings had revenue of $49.87M in the quarter ending December 31, 2025, a decrease of -11.83%.

Revenue (ttm)
$185.74M
Revenue Growth
-28.34%
P/S Ratio
4.93
Revenue / Employee
$426,995
Employees
435
Market Cap
915.16M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025185.74M-73.44M-28.34%
Dec 31, 2024259.19M-29.76M-10.30%
Dec 31, 2023288.95M-594.06M-67.28%
Dec 31, 2022883.00M83.76M10.48%
Dec 31, 2021799.24M515.14M181.33%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fortrea Holdings 2.72B
Phathom Pharmaceuticals 175.11M
Xencor 125.58M
CytomX Therapeutics 76.20M
Evommune 13.00M
Janux Therapeutics 10.00M
Compass Therapeutics 850.00K
Revenue Rankings

MRVI News

More News